![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 5
2022
Li, Xiao; Wu, Liangliang; Zheng, Zhiying; Liu, Hanyuan; Li, Haiyang; Sun, Guoqiang; Sun, Guangshun; Cheng, Ye; Wang, Hanjin; Li, Zhouxiao; Shi, Junfeng und Tang, Weiwei
(2022):
Tegaserod Maleate Inhibits Breast Cancer Progression and Enhances the Sensitivity of Immunotherapy.
In: Journal of Oncology, Bd. 2022, 5320421
2021
Sun, Guoqiang; Rong, Dawei; Li, Zhouxiao; Sun, Guangshun; Wu, Fan; Li, Xiao; Cao, Hongyong; Cheng, Ye; Tang, Weiwei und Sun, Yangbai
(8. September 2021):
Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges.
In: Frontiers in Cell and Developmental Biology, Bd. 9, 694363
[PDF, 5MB]
Li, Zhouxiao; Cheng, Ye; Fu, Kai; Lin, Qiaowei; Zhao, Tianyu; Tang, Weiwei; Xi, Lei; Sheng, Lulu; Zhang, Hao und Sun, Yangbai
(2021):
Circ-PTPDC1 promotes the Progression of Gastric Cancer through Sponging Mir-139-3p by Regulating ELK1 and Functions as a Biomarker.
In: International Journal of Biological Sciences, Bd. 17, Nr. 15: S. 4285-4304
2020
Tang, Weiwei; Chen, Ziyi; Zhang, Wenling; Cheng, Ye; Zhang, Betty; Wu, Fan; Wang, Qian; Wang, Shouju; Rong, Dawei; Reiter, F. P.; De Toni, E. N. und Wang, Xuehao
(2020):
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects.
In: Signal Transduction and Targeted Therapy, Bd. 5, Nr. 1
Li, Zhouxiao; Cheng, Ye; Wu, Fan; Wu, Liangliang; Cao, Hongyong; Wang, Qian und Tang, Weiwei
(2020):
The emerging landscape of circular RNAs in immunity: breakthroughs and challenges.
In: Biomarker Research, Bd. 8, Nr. 1, 25